首页|人免疫球蛋白联合肺保护性通气对重症肺炎伴呼吸衰竭患者的治疗效果

人免疫球蛋白联合肺保护性通气对重症肺炎伴呼吸衰竭患者的治疗效果

扫码查看
目的 探讨人免疫球蛋白联合肺保护性通气治疗重症肺炎伴呼吸衰竭的效果.方法 60 例重症肺炎伴呼吸衰竭患者根据治疗方法的不同分为两组各 30 例.对照组接受肺保护性通气治疗,观察组接受人免疫球蛋白联合肺保护性通气治疗.比较两组的呼吸相关指标、机体炎性指标、不良反应.结果 治疗后,观察组的PaO2、呼吸频率、心率值均高于对照组,PaCO2 值以及血清IL-6、IL-8、TNF-α水平均低于对照组(P<0.05).结论 人免疫球蛋白联合肺保护性通气治疗重症肺炎伴呼吸衰竭患者可有效改善其呼吸状况,减轻其机体炎性反应,安全性高.
Therapeutic Effect of Human Immunoglobulin Combined with Lung Protective Ventilation on Patients with Severe Pneumo-nia Complicated with Respiratory Failure
Objective To explore the effect of human immunoglobulin combined with lung protective ventilation in the treatment of severe pneumonia complicated with respiratory failure.Methods 60 patients with severe pneumonia complicated with respiratory failure were divided into two groups according to different treatment methods,with 30 cases in each group.The control group was treated with lung protective ventilation,and the observation group was treated with human immunoglobulin combined with lung protective ventilation.The respiratory related indicators,body inflammatory indicators and adverse reactions were compared between the two groups.Results After treatment,the values of PaO2,respiratory rate and heart rate in the observation group were higher than those in the control group,and PaCO2 value and the levels of serum IL-6,IL-8 and TNF-α were lower than those in the control group(P<0.05).Conclusions Human immunoglobulin combined with lung protective ventilation in the treatment of patients with severe pneumonia complicated with respiratory failure can effectively improve their respiratory status and relieve their inflammatory response,with high safety.

Severe pneumoniaRespiratory failureHuman immunoglobulinLung protective ventilation

何鹏、赵敏、韦安猛

展开 >

商丘市第一人民医院 药剂科,河南 商丘 476100

商丘市第一人民医院 呼吸内科,河南 商丘 476100

重症肺炎 呼吸衰竭 人免疫球蛋白 肺保护性通气

2024

临床医学工程
国家医疗保健器具工程技术研究中心

临床医学工程

影响因子:0.193
ISSN:1674-4659
年,卷(期):2024.31(12)